ESCMID weekly news 17.01.2023

Weekly News

Having trouble viewing this email? View in your browser.

WEEKLY NEWS

17 January 2023

Two ESCMID Guidelines projects under public consultation

ESCMID has opened public consultation phase for two clinical guidelines projects "Rituals and behaviours in the operating theatre" and "The EFLM European Urinalysis Guideline, update 2023". ESCMID members are welcome to comment on the manuscripts before the consultation phases close in early February. Learn more about the individual projects and how to get access on our website.

IMPORTANT DATES AND DEADLINES

17 January 2023 | Online registration deadline

Update on current emerging infections

.

18 January 2023 | Registration deadline

Antimicrobial stewardship in low and middle-income countries

.

30 January 2023 | Application deadline

Mayo Clinic Observership

.

31 January 2023 | Application deadline

Open call for clinical practice guidelines panel members

Open call for Editor-in-Chief of new ESCMID Journal

ESCMID is launching a new Gold Open Access journal to expand its publishing portfolio next to the highly successful ESCMID journal - Clinical Microbiology and Infection. For this reason, we are currently looking for highly qualified candidates to apply to be Editor-in-Chief and shape the Editorial strategy of the new journal. Interested candidates can see the full call description and apply now until 28 February 2023.

Register now for ESCMID onsite course in Homburg/Saar, Germany, 17-19 March 2023

The aims of the course are to enable participants to diagnose and classify infectious diseases in the context of travel and migration and develop diagnostic strategies and treatment options for selected travel- and migration- associated infections.

International Conference on One Health Antimicrobial Resistance (ICOHAR) 2023

ICOHAR is returning this year for the third time in Copenhagen, Denmark from 18-20 April, directly following ECCMID. The programme extends beyond zoonotic transfer of AMR to encompass the numerous AMR-related challenges shared by clinicians, clinical microbiologists, infectious disease specialists and researchers working in these sectors. Abstract submission is closing soon on January 30th so be sure to submit your research to be included and register before January 31st to avoid late fees.

ESCMID Course: Forensic medicine and management of pandemics

This ESCMID Online course will take place on 1-2 of March 2023 and cover lessons learned in forensic medicine that can help to improve their management in elderly and vulnerable patients. The course is organized by ESGFOR and ESGIE and reduced registrations will be available for trainees presenting a poster about forensic microbiology/ forensic pathology. Learn more and apply before February 1st.

EMA: Facilitating Decentralised Clinical Trials in the EU

The European Commission, the Heads of Medicines Agencies and the European Medicines Agency have published recommendations that aim to facilitate the conduct of decentralised clinical trials while safeguarding the rights and well-being of participants as well as the robustness and reliability of the data collected.

Effects of empiric antibiotic treatment based on hospital cumulative antibiograms in sepsis patients with bacteremia

Apply for the ESCMID special funded observership to the MAYO Clinic. Deadline to apply is 30 January

ESCMID Executive Office
Gerbergasse 14
4001 Basel
Switzerland

Phone +41 61 508 0150
info@escmid.org
www.escmid.org

.

The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program's address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.

.
. .
Nahoru